Related references
Note: Only part of the references are listed.Variable Temperature NMR Experiment Studying Restricted Bond Rotation
Michael T. Huggins et al.
JOURNAL OF CHEMICAL EDUCATION (2020)
Diastereoselective Intramolecular [3+2]-Annulation of Donor-Acceptor Cyclopropane with Imine-Assembling Hexahydropyrrolo[3,2-c]quinolinone Scaffolds
Jun-An Xiao et al.
JOURNAL OF ORGANIC CHEMISTRY (2016)
Asymmetric Annulation of Donor-Acceptor Cyclopropanes with Dienes
Hao Xu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Carbocycles from donor-acceptor cyclopropanes
Huck K. Grover et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
A New Golden Age for Donor-Acceptor Cyclopropanes
Tobias F. Schneider et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Exploring the Ligand Recognition Properties of the Human Vasopressin V1a Receptor Using QSAR and Molecular Modeling Studies
Martha C. Contreras-Romo et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2014)
Intramolecular donor-acceptor cyclopropane ring-opening cyclizations
Marchello A. Cavitt et al.
CHEMICAL SOCIETY REVIEWS (2014)
Remote Ester Groups Switch Selectivity: Diastereodivergent Synthesis of Tetracyclic Spiroindolines
Jun Zhu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Design, synthesis and structure-activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors
Maria-Carmen Fernandez et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Highly Diastereoselective Construction of Fused Carbocycles from Cyclopropane-1,1-dicarboxylates and Cyclic Enol Silyl Ethers: Scope, Mechanism, and Origin of Diastereoselectivity
Jian-Ping Qu et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Selective Fluorescent Nonpeptidic Antagonists For Vasopressin V2 GPCR: Application To Ligand Screening and Oligomerization Assays
Stephanie Loison et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol A Randomized Controlled Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure
Guoqing Cao et al.
JOURNAL OF LIPID RESEARCH (2011)
Non-peptide arginine-vasopressin antagonists: the vaptans
Guy Decaux et al.
LANCET (2008)
Solid-phase preparation of a pilot library derived from the 2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-amine scaffold
Damien Boeglin et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2007)
Donor-acceptor-substituted cyclopropane derivatives and their application in organic synthesis
HU Reissig et al.
CHEMICAL REVIEWS (2003)
Characterization of orally active nonpeptide vasopressin V2 receptor agonist.: Synthesis and biological evaluation of both the (5R)- and (5S)-enantioisomers of 2-[1-(2-chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-5-yl]-N-isopropylacetamide
K Kondo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
First total synthesis of martinellic acid, a naturally occurring bradykinin receptor antagonist
DW Ma et al.
ORGANIC LETTERS (2001)
Share Paper
